ZYNRELEF 400 mg/14mL
BUPIVACAINE and MELOXICAM · SOLUTION · Heron Therapeutics, Inc.
ZYNRELEF is a solution containing bupivacaine and meloxicam at 400 mg/14mL, taken infiltration. Manufactured by Heron Therapeutics, Inc..
Key Facts
- Brand Name
- ZYNRELEF
- Generic Name
- BUPIVACAINE and MELOXICAM
- NDC Code (Product)
47426-501- Manufacturer
- Heron Therapeutics, Inc.
- Strength
- 400 mg/14mL
- Dosage Form
- SOLUTION
- Route
- INFILTRATION
- Marketing Status
- Application #
- NDA211988
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Amide Local Anesthetic [EPC]
- Marketing Start
- 12/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is ZYNRELEF used for?
ZYNRELEF contains BUPIVACAINE and MELOXICAM. It is a solution taken infiltration. Consult your doctor for specific uses.
Is ZYNRELEF a controlled substance?
ZYNRELEF is not classified as a controlled substance by the DEA.
What is the generic name for ZYNRELEF?
The generic name for ZYNRELEF is BUPIVACAINE and MELOXICAM. There are no other listed brand versions of BUPIVACAINE and MELOXICAM.
What is the NDC code for ZYNRELEF 400 mg/14mL?
The NDC (National Drug Code) for ZYNRELEF 400 mg/14mL is 47426-501, listed by Heron Therapeutics, Inc..
Other ZYNRELEF Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)